Abstract
The iodinated cocaine derivative [(123)I]PE2I is a new selective ligand for in vivo studies of the dopamine transporter (DAT) with SPECT. Recently, a bolus/infusion (B/I) protocol for [(123)I]PE2I measurements of DAT density was established [Pinborg LH et al. J Nucl Med 2005;46:1119-271]. The aims of this study were, firstly, to evaluate the test-retest variability using the B/I protocol and, secondly, to evaluate the B/I approach in a new group of healthy subjects using two outcome parameters, BP(1) (C(ROI)/C(plasma)) and BP(2) (C(ROI)/C(REF)).
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | European Journal of Nuclear Medicine and Molecular Imaging |
| Vol/bind | 34 |
| Udgave nummer | 1 |
| Sider (fra-til) | 101-9 |
| Antal sider | 9 |
| ISSN | 1619-7070 |
| DOI | |
| Status | Udgivet - 1 jan. 2007 |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Reproducibility of [123I]PE2I binding to dopamine transporters with SPECT'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS